MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gassur.2026.102560

Медицинская библиотека · Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026

Endoscopic transoral outlet reduction for weight recurrence after Roux-en-Y gastric bypass: a retrospective single-center analysis.

Da Canal Francesca, Di Pietro Martinelli Claudine, Potoczna Natascha, Wiegand Nico, Peros Georgios, Gantert Walter, Lazaridis Ioannis I, Sidler Mirjam H, Delko Tarik

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Weight recurrence after Roux-en-Y gastric bypass affects 25% of patients. Gastrojejunal anastomosis dilation is a modifiable contributor. This study evaluates the efficacy and safety of endoscopic transoral outlet reduction (TORe), comparing suturing vs over-the-scope clips (OTSC).

METHODS

Retrospective analysis of consecutive patients undergoing TORe for weight recurrence (2012-2024) at a tertiary center. Treatments included endoscopic suturing (OverStitch, Boston Scientific), OTSC, or a combination of techniques. Outcomes included percentage total body weight loss (%TWL) and symptomatic remission of dumping syndrome at 3, 6, 12, and 24 months, with 12 months as the primary reference time point (80.6% follow-up). Additional outcomes included technical success and 30-day adverse events.

RESULTS

Ninety-three patients were included (47.3 ± 11.5 years; 81.7% female). Techniques used were: suturing, n = 48 (51.6%); OTSC, n = 33 (35.5%); combined, n = 8 (8.6%); and Bariatric Anastomotic Repair System, n = 4 (4.3%). Baseline body mass index was 32.6 ± 5.4 kg/m². Mean gastrojejunal anastomosis diameter was reduced from 25.0 ± 7.0 mm to 10.7 ± 2.1 mm (P <.001), with a technical success rate of 97.8%. At 12 months, %TWL was 1.1 ± 6.4% (Suturing: -0.1 ± 5.4% vs 1.5 ± 6.4%; P =.61). Among 47 patients (50.5%) with dumping syndrome, symptomatic remission was achieved in 74.4% at 3 months and in 61.9% at 12 months. The suturing group (n = 23) achieved 89.5% symptomatic remission at 3 months and 71.4% at 12 months, vs the OTSC group (n = 21), which achieved 60.0% and 52.4%, respectively (12-month odds ratio, 2.27; 95% CI, 0.71-7.84; P =.341). The adverse event rate was 6.5%.

CONCLUSION

TORe achieves excellent anatomical reduction. Although weight outcomes were heterogeneous (mean %TWL was 1.1%; 42.7% experienced continued weight gain), dumping syndrome symptomatic remission was substantial (61.9% at 12 months), supporting TORe as an anatomical stabilization measure within multidisciplinary obesity management rather than a standalone weight-loss intervention.

Для цитирования: Da Canal Francesca, Di Pietro Martinelli Claudine, Potoczna Natascha, Wiegand Nico, Peros Georgios, Gantert Walter, Lazaridis Ioannis I, Sidler Mirjam H, Delko Tarik. Endoscopic transoral outlet reduction for weight recurrence after Roux-en-Y gastric bypass: a retrospective single-center analysis.. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2026. DOI: 10.1016/j.gassur.2026.102560.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.